** Jefferies analysts maintain "buy" rating on Australia's ALS Ltd ALQ.AX at a price target of A$18.80 per share
** The testing services provider will report its FY25 results on May 27
** According to Jefferies, ALQ's biggest delta, minerals, has had a negative sample volume growth, which has been a drag for the company in most of FY24 and FY25
** At the April 28 trading update, we got confirmation that this has flipped to being a positive driver — Jefferies
** Brokerage says there should be few surprises in the FY results; sees promising signs for medium-term growth
** Stock has risen 17.6% this year, as of last close
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。